Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.

doi:10.1093/jac/33.4.729

Back to search

Article

Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.

The Journal of antimicrobial chemotherapy - 1 Apr 1994

Heym B, Lacroix O, Péan Y, Gertner J, Nicolas M H, Jarlier V

Abstract excerpt

To determine if susceptibility to aztreonam could be predicted from cefotaxime or ceftazidime disc diffusion testing, 919 Enterobacteriaceae and 187 Pseudomonas aeruginosa clinical strains were studied. The correlation coefficient between the diameters of inhibition zones was 0.9 for cefotaxime v...

Topics

Aztreonam
Cefotaxime
Ceftazidime
Enterobacteriaceae
Microbial Sensitivity Tests
Penicillin Resistance
Phenotype
Pseudomonas aeruginosa
Ticarcillin
beta-Lactamases

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.